相关实验视频

Updated: Jul 25, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

以分子对接为基础的相互作用研究,研究 imidazo[1,2-a] 氨酸乙烯和 squaramides 作为抗结核剂

S Ahmed^1,2, A E Prabahar², A K Saxena¹

¹Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research, Kashipur, India.

SAR and QSAR in environmental research

|June 27, 2023

概括

由于耐药性,新的抗结核剂至关重要. 一种新的定量方法准确地预测了ATP合成酶抑制,有助于发现潜在的新抗结核药物.

科学领域:

药用化学医学化学
计算化学的计算化学
药物发现药物发现药物发现

背景情况:

耐药性需要开发新的抗结核药物,以针对ATP合成酶等验证的途径.
传统的基于结构的药物设计 (SBDD) 经常显示对接得分和生物活性之间的相关性很差.

研究的目的:

通过将氨基酸残留相互作用与生物活性相关联,开发一种新的定量方法来预测抗结核活性.
确定用于结核病治疗的ATP合成酶的新型抑制剂.

主要方法:

基于氨基酸残留与目标蛋白的相互作用的定量结构-活性关系 (QSAR) 建模.
预测ATP合成酶抑制活性的伊米达佐[1,2-a]氨酸和方胺.
分子动力学模拟以评估联结蛋白复合体的稳定性.

主要成果:

一种新的方法成功预测了高相关系数的ATP合成酶抑制活性 (例如,Glu65b相互作用的r=0.84).
开发的模型在培训,多样化,测试和外部数据集中表现出强大的预测能力.
确定了三种具有高抑制活性的新型化合物 (pIC50在0.0508-0.1494μM范围内).

结论:

开发的定量模型克服了传统SBDD的局限性,使得可以准确预测抗结核活性.
这种方法有助于识别和优化针对ATP合成酶的新型抗结核化合物.
这些发现支持该模型在加速发现抗结核新药方面的潜在实用性.

关键词:

这是ATP合成酶.在CABS-flex中使用.在QSAR中使用QSAR.这就是SBDDSBDD的意思.结核病是一种疾病.接互动的互动.

更多相关视频

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Basicity of Heterocyclic Aromatic Amines

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...